Cover Image

Effectiveness of oral direct antiviral agents against chronic hepatitis C virus infection for HIV/HCV co-infected patients: a success story from a prospective cohort

Saved in:

Bibliographic Details
Main Authors:	Guillaume Laurichesse (Author), S. Casanova (Author), A. Mirand (Author), V. Corbin (Author), N. Mrozek (Author), M. Vidal (Author), C. Henquell (Author), J. Beytout (Author), C. Jacomet (Author), H. Laurichesse (Author)
Format:	Book
Published:	Elsevier, 2016-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Biological hepatic markers of inflammation and fibrosis following durable sustained virological response to direct acting antiviral agents in HIV/HCV co-infected patients: preliminary results from the cohort driven by the CoReVIH at the University-Hospital of Clermont-Ferrand, France
by: Guillaume Laurichesse, et al.
Published: (2018)

P29 Treating hepatitis C virus infection (HCV) with direct acting antivirals (DAAs) through the existing infrastructure of opioid agonist therapy (OAT)
by: J. Keats, et al.
Published: (2017)

Timing Strategies of Direct-Acting Antivirals and Biologics Administration in HCV-Infected Subjects with Inflammatory Bowel Diseases
by: Nicola Imperatore, et al.
Published: (2017)

Immunological Dynamics Associated with Direct-Acting Antiviral Therapies in Naive and Experimented HCV Chronic-Infected Patients
by: Grenda Leite Pereira, et al.
Published: (2019)

Effectiveness of triple therapy with direct-acting antivirals for hepatitis C genotype 1 infection: application of propensity score matching in a national HCV treatment registry
by: Emma Gray, et al.
Published: (2017)

Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in Nepal.
by: Sudhamshu Kc, et al.
Published: (2020)

Effect of sustained virological response after direct-acting antivirals on liver fibrosis in patients with chronic HCV infection
by: Ramy H. Agwa, et al.
Published: (2022)

Management of Hepatitis C Infection with Direct Action Antiviral Drugs (DAA)**
by: Roberto Focaccia, et al.
Published: (2015)

IP-10 Interferes With the Antiviral Response of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection
by: Yadong Wang, et al.
Published: (2022)

Direct action antivirals are effective in the total eradication of HCV in renal transplants
by: Teresa Olea, et al.
Published: (2019)

A study on the prevalence of HCV genotypes and the effect of direct-acting antiviral therapy on clinical and laboratory parameters in HCV-Infected patients at a tertiary care center in North India
by: S Muhammed Shahanas, et al.
Published: (2024)

The effect of different direct antivirals on hepatic steatosis in nondiabetic and naïve hepatitis C-infected Egyptian patients
by: Ahmed El-Ghandour, et al.
Published: (2023)

Sustained virological response rates with direct-acting antivirals in black subjects with HCV genotype 1 infection: systematic analysis of clinical trials
by: Kimberly Struble, et al.
Published: (2019)

Autoimmune hepatitis associated Hepatitis C virus infection treated with fi rst generation direct-acting antivirals
by: Juan Diego Castro Limo, et al.
Published: (2019)

Future destinations and social inclusion scoping review: how people cured of hepatitis C (HCV) using direct- acting antiviral drugs progress in a new HCV-free world
by: Sarah R. Donaldson, et al.
Published: (2022)

Drug-drug interactions between antithrombotics and direct-acting antivirals in hepatitis C virus (HCV) patients: A brief, updated report
by: Mario Enrico Canonico, et al.
Published: (2022)

Virus infection and direct-acting antivirals in pregnancy
by: Xuan Huang, et al.
Published: (2022)

Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection
by: Mohamed M Sakr, et al.
Published: (2019)

The epidemiological changes of HCV and HBV infections in the era of new antiviral therapies and the anti-HBV vaccine
by: Cristina Stasi, et al.
Published: (2016)

Hepatitis C Virus Infection and HCV Genotypes of Hemodialysis Patients
by: K Samimi-rad, et al.
Published: (2008)

Hepatitis C Virus Infection and HCV Genotypes of Hemodialysis Patients
by: K Samimi-rad, et al.
Published: (2008)

The efficacy and safety of direct-acting antiviral regimens for end-stage renal disease patients with HCV infection: a systematic review and network meta-analysis
by: Ruochan Chen, et al.
Published: (2023)

Patients' preferences for treatment with the new direct acting antiviral therapies for chronic hepatitis C virus infection
by: MA Simón, et al.
Published: (2021)

Direct Acting Antivirals in Hepatitis C-Infected Kidney Transplant Recipients: Associations with Long-term Graft Failure and Patient Mortality
by: Michael R Goetsch, et al.
Published: (2020)

Emergence and Persistence of Resistance-Associated Substitutions in HCV GT3 Patients Failing Direct-Acting Antivirals
by: Saima Mushtaq, et al.
Published: (2022)

O5 Hepatitis C elimination in HIV/HCV co-infection through HCV treatment in primary care is feasible and highly effective
by: J.S. Doyle, et al.
Published: (2017)

Identification of the Genotypes Circulating in the Ecuadorian Population Infected with the Hepatitis C Virus (HCV)
by: Moncayo M, et al.
Published: (2023)

Factors Associated with Hepatitis C Infection among Chronic HCV Egyptian Patients.
by: Ekram W Abd El-Wahab, et al.
Published: (2014)

Efficacy and safety of direct-acting antivirals for treatment of hepatitis C infected kidney transplant recipients; a meta-analysis
by: Wisit Cheungpasitporn, et al.
Published: (2017)

The effect of direct acting antiviral agents on vascular endothelial function in Egyptian patients with chronic hepatitis C virus infection
by: Dalia A Freekh, et al.
Published: (2021)

Impact of direct acting antiviral agents on kidney function in hepatitis C virus infected patients with chronic kidney disease
by: Wedad Adel Mahmoud, et al.
Published: (2021)

Molecular Study of Occult Hepatitis C Infection among Iranian Hemophilia Patients Treated with Direct-acting Antiviral Agents
by: Elnaz Agi, et al.
Published: (2020)

Viral genotype and HLA class II alleles influence on extra-hepatic manifestations of chronic HCV infection
by: M. Galeazzi, et al.
Published: (2011)

Assessing the level of knowledge and available sources of information about hepatitis C infection among HCV-infected Egyptians
by: Noha Yahia Sultan, et al.
Published: (2018)

Direct-acting Antivirals in Kidney Transplant Patients: Successful Hepatitis C Treatment and Short Term Reduction in Urinary Protein/Creatinine Ratios
by: Michael R. Goetsch, et al.
Published: (2017)

Assessment of thyroid function in patients with chronic hepatitis C virus infection before and after treatment with oral direct-antiviral drugs
by: Fathy Ghamry Abdelrazik, et al.
Published: (2021)

An in vitro study of an Artocarpus heterophyllus substance as a hepatitis C antiviral and its combination with current anti-HCV drugs
by: Adita Ayu Permanasari, et al.
Published: (2021)

Direct anti-HCV agents
by: Xingquan Zhang
Published: (2016)

Oral lichen planus and HCV infection
by: Jefferson R. Tenório, et al.
Published: (2021)

Multidisciplinary approach for the treatment of 1155 HCV/HCV-HIV co-infected patients
by: Isabelle Ravaux, et al.
Published: (2016)